CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Business Segments Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.61 USD | +2.21% |
|
+5.67% | -15.99% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Discovery and Safety Assessment (DSA) | 1.62B | 1.84B | 2.11B | 2.45B | 2.62B | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -86.84M | -106M | -101M | -190M | -205M | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | 151M | 169M | 177M | 179M | 175M | |||||
Operating Income | 259M | 326M | 407M | 533M | 606M | |||||
Research Models and Services (RMS) | 537M | 571M | 690M | 739M | 792M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -26.99M | -29.49M | -61.19M | -44.14M | -52.82M | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | 19.2M | 37.08M | 39.12M | 49.27M | 55.57M | |||||
Operating Income | 134M | 103M | 167M | 160M | 155M | |||||
Pharmaceutical Contract Laboratories | ||||||||||
Manufacturing | 465M | 515M | 742M | 790M | 721M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -23.62M | -26.29M | -58.88M | -87.08M | -58.13M | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | 23.58M | 25.9M | 46.2M | 72.95M | 79.98M | |||||
Operating Income | 145M | 181M | 246M | 167M | 88.33M | |||||
CAPEX | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -37.86M | -34.11M | -43.02M | - | - | |||||
Operating Income | -73.89M | -73.81M | -92.46M | - | - | |||||
Operating Income | -16.64M | -26.56M | -25.37M | - | - | |||||
Operating Income | -16.08M | -18.91M | -18.45M | - | - | |||||
Operating Income | -4.18M | -3.02M | -2.97M | - | - | |||||
Operating Income | -11.56M | -7.02M | -17.68M | - | - | |||||
CAPEX | -3.06M | -5.13M | -7.23M | -3.95M | -2.68M | |||||
D&A | 4.18M | 3.02M | 2.97M | 2.18M | 3.85M | |||||
Operating Income | - | - | - | -209M | -232M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S) | 1.47B | 1.63B | 1.93B | 2.34B | 2.35B | |||||
Total Assets | 603M | 628M | 755M | 896M | 964M | |||||
Europe | 726M | 829M | 1.04B | 1.03B | 1.08B | |||||
Total Assets | 254M | 286M | 323M | 349M | 407M | |||||
Canada | 272M | 306M | 339M | 399M | 487M | |||||
Total Assets | 127M | 145M | 145M | 135M | 157M | |||||
Asia Pacific | 146M | 155M | 223M | 193M | 201M | |||||
Total Assets | 60.21M | 62.93M | 64.86M | 82.78M | 74.6M | |||||
Other | 5.5M | 6.13M | 7.29M | 9.96M | 16.85M | |||||
Total Assets | 101K | 1.92M | 2.12M | 1.98M | 36.1M | |||||
Japan | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
MarketScreener is also available in this country: United States.
Switch edition